ADAR1 Capital Management’s Silence Therapeutics SLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$108K Hold
18,643
0.02% 163
2025
Q1
$52.6K Buy
18,643
+643
+4% +$1.81K 0.01% 174
2024
Q4
$124K Sell
18,000
-22,290
-55% -$153K 0.02% 164
2024
Q3
$732K Hold
40,290
0.12% 89
2024
Q2
$766K Buy
40,290
+200
+0.5% +$3.8K 0.14% 73
2024
Q1
$866K Buy
40,090
+39,900
+21,000% +$862K 0.2% 57
2023
Q4
$3.3K Buy
+190
New +$3.3K ﹤0.01% 133